Da Zhang

Dr. Da Zhang is a Professor in the Department of Pathology and Laboratory Medicine at the University of Kansas Medical Center. He serves as Program Director of the Hematopathology Fellowship, Director of Hematopathology, and Medical Director of the Bone Marrow Lab. His roles integrate clinical leadership, academic research, and fellowship training program management.

• Education: MD in Medicine from Shandong Medical University, MSC in Science from Chinese Center for Disease Control and Prevention

Research Interests: Dr. Zhang's translational research focuses on hematopoietic neoplasms and genitourinary (GU) malignancies, with particular emphasis on Castleman's disease, lymphomas, and leukemia. His work explores molecular pathways (e.g., Wnt signaling) and biomarkers in hematological and solid tumors.

Publication Trends: In 2022, Dr. Zhang published studies on diagnostic methodologies in leukemia, prognostic biomarkers in prostate cancer, and molecular genetic comparisons across hematological disorders. His work bridges clinical practice (flow cytometry applications) and mechanistic research (AR/Wnt signaling in cancer progression).

• Scientific Awards
  • Fellow, College of American Pathologists (2007–Present)
  • Fellow, United States and Canadian Academy of Pathology (2007–Present)

Labs & Teams: As Medical Director of the Bone Marrow Lab and director of the Hematopathology program, Dr. Zhang leads clinical and research operations in hematological diagnostics and training initiatives.